SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001016169-09-000044
Filing Date
2009-08-14
Accepted
2009-08-14 11:37:49
Documents
3
Period of Report
2009-08-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 hobbsboard.htm 8-K 30580
2 PRESS RELEASE pressrelease.htm EX-99 7586
3 GRAPHIC img1.jpg GRAPHIC 3740
  Complete submission text file 0001016169-09-000044.txt   45391
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 091013400
SIC: 3841 Surgical & Medical Instruments & Apparatus